798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a...

Saved in:

Published in:	Blood 124(2014,21) Artikel-Nr. 76104, 1 S.
Authors and Corporations:	Ottmann, Oliver G. (Other), Heidenreich, Daniela (Other)
Title:	798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02)/ Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot
Type of Resource:	E-Book Component Part Conference Proceedings
Language:	English
published:	2014
Series:	: Blood, 124(2014,21) Artikel-Nr. 76104, 1 S. , volume:124
Subjects:	Konferenzschrift
Source:	Verbunddaten SWB Lizenzfreie Online-Ressourcen